Jurors in state court in Baltimore late Monday concluded that J&J, two of its units and spinoff Kenvue were liable for failing to warn Cherie Craft that its baby powder was tainted with asbestos, which researchers have linked to mesothelioma, a form of cancer. J&J officials say the parent company is responsible for covering the entire verdict since it agreed to indemnify Kenvue for all baby powder liabilities.
The verdict comes as J&J has been pummeled by a recent spate of baby powder verdicts after it failed this year to use
J&J steadfastly maintains talc doesn’t cause cancer and there’s never been any asbestos in the product. The company also contends it has appropriately marketed its baby powder for more than 100 years.
‘Patently Unconstitutional’
“We will immediately appeal this egregious and patently unconstitutional verdict that is the direct result of the gross errors made by the trial court that allowed plaintiff’s counsel to pervade the record with improper and prejudicial statements and assertions,” said
Representatives of Kenvue, which spun off from J&J in 2023, didn’t immediately respond to an email seeking comment outside regular business hours.
“The jury heard evidence that J&J kept from regulators, doctors and it customers decades of evidence that its baby powder contained asbestos,” Jessica Dean, a Dallas-based lawyer representing Craft, said in an emailed statement. “J&J continues to deny this evidence and refuses to do the right thing by those who were hurt by their actions.”
While J&J already has spent more than $3 billion settling lawsuits alleging asbestos in its baby powder harmed users, the company still faces more than 70,000 claims the product caused mesothelioma and ovarian cancers. Many of those cases have been consolidated before a federal judge in New Jersey for pre-trial information exchanges. J&J pulled its talc-based version of baby powder off the worldwide market in 2022 and replaced it with a cornstarch alternative.
Verdicts Reduced
More than a dozen juries have held J&J and Kenvue responsible for baby powder users’ cancers and awarded billions of dollars in damages in total. Some of those awards later were reduced or thrown out on appeal.
The largest trial verdict against J&J was a $4.7 billion jury award in 2018 to 22 women in state court in Missouri. An appeals court cut the verdict to
J&J unsuccessfully tried three times to use the US bankruptcy process to force a settlement of the baby powder cases and now faces a wave of trials in the regular court system.
This month, a state-court jury in Los Angeles ordered J&J to pay $40 million to two women who alleged their baby powder use caused their ovarian cancers. It was the first verdict in an ovarian cancer case since 2021 because those cases have been delayed by repeated Chapter 11 filings by J&J subsidiaries. Meanwhile, a Minnesota jury hit J&J with a verdict of more than $65 million in another mesothelioma case.
Jurors in the Baltimore case awarded Craft $60 million to compensate her for injuries and losses, plus punitive damages of $1 billion against J&J and $500 million against Pecos River Talc LLC, a unit of J&J set up as part of its bankruptcy efforts.
40 Years
Craft’s lawyers argued the 54-year-old woman used J&J’s talc-based baby powders for more than 40 years before being diagnosed with mesothelioma.
Talc and asbestos are similar minerals and often found together when mined.
The Baltimore jury found evidence that J&J, Kenvue and the other units engaged in “fraudulent misrepresentation or concealment” about the powder’s cancer risks and used “unlawful means” in selling their product and awarded punitive damages.
The case is Craft v. Ahold Delhaize US Inc., 24-X-000005, Baltimore City Circuit Court.
(Updates with plaintiff lawyer’s comment in seventh paragraph)
To contact the reporter on this story:
To contact the editors responsible for this story:
Peter Blumberg
© 2025 Bloomberg L.P. All rights reserved. Used with permission.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.